Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins

被引:6
|
作者
Rasapalli, Sivappa [1 ]
Sammeta, Vamshikrishna Reddy [1 ]
Murphy, Zachary F. [1 ]
Golen, James A. [1 ]
Agama, Keli [2 ,3 ]
Pommier, Yves [2 ,3 ]
Savinov, Sergey N. [4 ]
机构
[1] Univ Massachusetts Dartmouth, Dept Chem & Biochem, 285 Old Westport Rd, N Dartmouth, MA 02747 USA
[2] NCI, Ctr Canc Res, Dev Therapeut Branch, Bethesda, MD 20892 USA
[3] NCI, Ctr Canc Res, Lab Mol Pharmacol, Bethesda, MD 20892 USA
[4] UMass Amherst, Dept Biochem & Mol Biol, Amherst, MA 01003 USA
关键词
aza-Nazarov; Quinazolinonyl enones; Vasicinone; uotonin A; Topoisomerase I; RING; DERIVATIVES; CYCLIZATION;
D O I
10.1016/j.bmcl.2021.127998
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A facile one-pot synthesis of C-ring substituted angular luotonins has been realized via a methanesulfonic acid mediated aza-Nazarov?Friedlander condensation sequence on quinazolinonyl enones. Topoisomerase I (topo-I) inhibition studies revealed that the angular luotonin library (7a-7l) and their regioisomeric analogs (linear luotonins, 8a-8l) are weak negative modulators, compared to camptothecin. These results would fare well for the design of topo-I-inert luotonins for non-oncological applications such as anti-fungal and insecticide lead developments. Surprisingly, the tricyclic vasicinones (9h, 9i, and 9j) showed better topo-I inhibition compared to pentacyclic C-aryl luotonins providing a novel pharmacophore for further explorations.
引用
收藏
页数:4
相关论文
共 1 条